Page 98 - L:\GROUP\SDT\zip_disk\Book2.PDF
P. 98

A APPENDIX FPPENDIX F




                    Section B of Introduction to               mouth or nasal passages, upper respiratory tract,
                    CDC Guidelines Pages 4-6                   and bronchi to reach the alveoli of the lungs.  Once
                                                               in the alveoli, the organisms are taken up by alveo-
          B.  Epidemiology, Transmission, and Pathogen-        lar macrophages and spread throughout the body.
          esis of TB
                                                               Usually within 2-10 weeks after initial infection
          The prevalence of TB is not distributed evenly       with M. tuberculosis, the immune response limits fur-
          throughout all segments of the U.S. population.      ther multiplication and spread of the tubercle ba-
          Some subgroups or persons have a higher risk for     cilli; however, some of the bacilli remain dormant
          TB either because they are more likely than other    and viable for many years.  This condition is re-
          persons in the general population to have been ex-   ferred to as latent TB infection.  Persons with latent
          posed to and infected with M. tuberculosis or be-    TB infection usually have positive purified protein
          cause their infection is more likely to progress to ac-  derivative (PPD)-tuberculin skin-test results, but
          tive TB after they have been infected (5). In some   they do not have symptoms of active TB, and they
          cases, both of these factors may be present. Groups  are not infectious.
          of persons known to have a higher prevalence of TB
          infection include contacts of persons who have ac-   In general, persons who become infected with M. tu-
          tive TB, foreign-born persons from areas of the      berculosis have approximately a 10% risk for devel-
          world with a high prevalence of TB (e.g., Asia, Af-  oping active TB during their lifetimes.  This risk is
          rica, the Caribbean, and Latin America), medically   greatest during the first 2 years after infection.
          underserved populations (e.g., some African-         Immunocompromised persons have a greater risk
          Americans, Hispanics, Asians and Pacific Islanders,  for the progression of latent TB infection to active TB
          American Indians, and Alaskan Natives), homeless     disease; HIV infection is the strongest known risk
          persons, current or former correctional-facility in-  factor for this progression.  Persons with latent TB
          mates, alcoholics, injecting-drug users, and the eld-  infection who become coinfected with HIV have ap-
          erly. Groups with a higher risk for progression      proximately an 8%-10% risk per year for develop-
          from latent TB infection to active disease include   ing active TB (8).  HIV- infected persons who are al-
          persons who have been infected recently (i.e.,       ready severely immunosuppressed and who become
          within the previous 2 years), children less than 4   newly infected with M. tuberculosis  have an even
          years of age, persons with fibrotic lesions on chest  greater risk for developing active TB (9-12).
          radiographs, and persons with certain medical con-
          ditions (i.e., human immunodeficiency virus {HIV}    The probability that a person who is exposed to M.
          infection, silicosis, gastrectomy or jejuno-ileal by-  tuberculosis will become infected depends primarily
          pass, being greater than or equal to 10% below       on the concentration of infectious droplet nuclei in
          ideal body weight, chronic renal failure with renal  the air and the duration of exposure.  Characteristics
          dialysis, diabetes mellitus, immunosuppression re-   of the TB patient that enhance transmission include
          sulting fro receipt of high-dose corticosteroid or   a) disease in the lungs, airways, or larynx; b) pres-
          other immunosuppressive therapy, and some ma-        ence of cough or other forceful expiratory measures;
          lignancies) (5).  M. tuberculosis is carried in air-  c) presence of acid-fast bacilli (AFB) in the sputum;
          borne particles, or droplet nuclei, that can be gener-  d) failure of the patient to cover the mouth and nose
          ated when persons who have pulmonary or              when coughing or sneezing ; e) presence of cavita-
          laryngeal TB sneeze, cough, speak, or sing (6).  The  tion on chest radiograph; f) inappropriate or short
          particles are an estimated 1-5 mm in size, and nor-  duration of chemotherapy; and g) administration of
          mal air currents can keep them airborne for pro-     procedures that can induce coughing or cause aero-
          longed time periods and spread them throughout a     solization of M. tuberculosis (e.g., sputum induction).
          room or building (7).  Infection occurs when a sus-  Environmental factors that enhance the likelihood
          ceptible person inhales droplet nuclei containing M.  of transmission include  a) exposure in relatively
          tuberculosis, and these droplet nuclei traverse the  small, enclosed spaces; b) inadequate local or gen-


                                                            90
   93   94   95   96   97   98   99   100   101   102   103